Skip to search.
 BSE Up0.19% NSE Up0.28%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM

28.01 Up 1.32(4.95%) 18 May 1:30AM|After Hours : 28.00 Down 0.01 (0.04%) 18 May 3:40AM

Add to Portfolio
Balance SheetGet Balance Sheet for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending31-Dec-201231-Dec-201131-Dec-2010
Assets
Current Assets
Cash And Cash Equivalents12,381  7,041  3,346  
Short Term Investments -  10,000  19,351  
Net Receivables8,916  12,544  13,602  
Inventory1,697  1,301   -  
Other Current Assets829  1,344  720  
Total Current Assets 23,823   32,230   37,019  
Long Term Investments8,207  15,255  22,851  
Property Plant and Equipment788  455  559  
Goodwill12,238  12,238  700  
Intangible Assets55,912  58,326  12,251  
Accumulated Amortization -   -   -  
Other Assets3,284  2,079  2,179  
Deferred Long Term Asset Charges8   -   -  
Total Assets 104,260   120,583   75,559  
Liabilities
Current Liabilities
Accounts Payable12,396  16,119  17,456  
Short/Current Long Term Debt14,835  10,000  5,296  
Other Current Liabilities8,208  17,524  10,736  
Total Current Liabilities 35,439   43,643   33,488  
Long Term Debt19,406  28,653  11,118  
Other Liabilities19,836  26,062  24,540  
Deferred Long Term Liability Charges3,094  5,696  2,918  
Minority Interest -   -   -  
Negative Goodwill -   -   -  
Total Liabilities 77,775   104,054   72,064  
Stockholders' Equity
Misc Stocks Options Warrants -  8,344  8,344  
Redeemable Preferred Stock -   -   -  
Preferred Stock -   -   -  
Common Stock21  21  21  
Retained Earnings(682,759)(682,232)(691,947)
Treasury Stock(42,280)(42,280)(42,225)
Capital Surplus751,503  732,676  729,271  
Other Stockholder Equity -   -  31  
Total Stockholder Equity 26,485   8,185   (4,849)
Net Tangible Assets (41,665) (62,379) (17,800)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.